Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myles Wolf

Showing results (201-210 of 308) with videos related to

Pageof 31
Sort By:
The Journal of Clinical Endocrinology and Metabolism|March 23, 2016
Fibroblast Growth Factor-23 (FGF-23) Levels Differ Across Populations by Degree of IndustrializationShennin N Yuen, Holly Kramer, Amy Luke, et al.
Journal of the American Society of Nephrology : JASN|April 11, 2008
Impact of activated vitamin D and race on survival among hemodialysis patientsMyles Wolf, Joseph Betancourt, Yuchiao Chang, et al.
Circulation|May 6, 2009
Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney diseaseOrlando M Gutiérrez, James L Januzzi, Tamara Isakova, et al.
Cytokine|January 8, 2017
Serum levels of fibroblast growth factor 23 are elevated in patients with active Lupus nephritisAline L Resende, Rosilene M Elias, Myles Wolf, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 1, 2017
Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing RisksJesse Yenchih Hsu, Jason A Roy, Dawei Xie, et al.
Kidney International|March 1, 2016
Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgeryDavid E Leaf, Marta Christov, Harald Jüppner, et al.
Kidney International|August 2, 2021
Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney diseaseRupal C Mehta, Monique E Cho, Xuan Cai, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 15, 2017
Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney DiseaseMichel Chonchol, Berenice Gitomer, Tamara Isakova, et al.
British Journal of Pharmacology|June 20, 2020
Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxisJoan Perelló, Miquel D Ferrer, Maria Del Mar Pérez, et al.
Journal of Bone and Mineral Metabolism|December 13, 2016
Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestryDominique Kosk, Holly Kramer, Amy Luke, et al.
Pageof 31

Showing results (201-210 of 308) with videos related to

Sort By:
Pageof 31
The Journal of Clinical Endocrinology and Metabolism|March 23, 2016
Fibroblast Growth Factor-23 (FGF-23) Levels Differ Across Populations by Degree of IndustrializationShennin N Yuen, Holly Kramer, Amy Luke, et al.
Journal of the American Society of Nephrology : JASN|April 11, 2008
Impact of activated vitamin D and race on survival among hemodialysis patientsMyles Wolf, Joseph Betancourt, Yuchiao Chang, et al.
Circulation|May 6, 2009
Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney diseaseOrlando M Gutiérrez, James L Januzzi, Tamara Isakova, et al.
Cytokine|January 8, 2017
Serum levels of fibroblast growth factor 23 are elevated in patients with active Lupus nephritisAline L Resende, Rosilene M Elias, Myles Wolf, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 1, 2017
Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing RisksJesse Yenchih Hsu, Jason A Roy, Dawei Xie, et al.
Kidney International|March 1, 2016
Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgeryDavid E Leaf, Marta Christov, Harald Jüppner, et al.
Kidney International|August 2, 2021
Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney diseaseRupal C Mehta, Monique E Cho, Xuan Cai, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 15, 2017
Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney DiseaseMichel Chonchol, Berenice Gitomer, Tamara Isakova, et al.
British Journal of Pharmacology|June 20, 2020
Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxisJoan Perelló, Miquel D Ferrer, Maria Del Mar Pérez, et al.
Journal of Bone and Mineral Metabolism|December 13, 2016
Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestryDominique Kosk, Holly Kramer, Amy Luke, et al.
Pageof 31